相关实验视频
Updated: Jan 12, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.8K
在HERC4下调节KRT19,促进肺腺癌,迁移,入侵和EMT
Hao-Jia Sun1, Ming-Hui Peng2, Zi-Yang Feng1
1Department of Oncology, Third Xiangya Hospital, Central South University, Changsha 410013 Hunan, China.
Translational oncology
|November 5, 2025
概括
低调KRT19促进肺腺癌转移通过增强上皮层-介质细胞过渡 (EMT). HERC4蛋白针对KRT19进行降解,增加癌细胞的传播和不良预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 的转移显著影响治疗失败和患者的预后.
- 表皮-介质细胞过渡 (EMT) 是LUAD转移的关键驱动因素.
- 肺肉类瘤 (PSC),一种罕见的LUAD亚型,表现出高转移潜力,EMT与瘤组件 (SaC) 形成有关.
研究的目的:
- 研究KRT19在LUAD转移中的作用及其调节.
- 阐明KRT19影响癌细胞行为的机制.
- 在LUAD进展的背景下,确定KRT19的上游调节者.
主要方法:
- 通过免疫组织化学对PSC成分 (SaC与癌性成分/CaC) 中KRT19的差异表达分析.
- 生物信息分析 (GO,KEGG) 探索KRT19的功能途径.
- 在体外 (CCK-8,伤口愈合,Transwell测定) 和体内 (老鼠模型) 实验中评估KRT19对LUAD细胞增殖,迁移和入侵的影响.
- 共同免疫沉 (CO-IP),GST下拉和无处不在测试以识别和验证KRT19的上游调节器.
主要成果:
- 与CaC和一般的LUAD相比,KRT19表达在SaC显著下调.
- 在LUAD细胞系中,KRT19敲击诱导了EMT,减少了细胞粘附,增加了LUAD细胞系中的增殖和转移 (A549,PC-9).
- HERC4被确定为一种上游调节器,它促进KRT19的无化和随后的下调,HERC4和KRT19水平之间的反相关性.
结论:
- 对KRT19的下调增强了LUAD细胞的EMT和转移潜力.
- HERC4通过促进其无处不在和降解,起到KRT19的上游抑制作用.
- 向HERC4-KRT19轴可能为抑制LUAD转移提供治疗策略.
相关概念视频
Cadherins in Tissue Organization
3.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.9K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K

